Previous 10 | Next 10 |
2024-06-14 14:38:51 ET Summary Avidity Biosciences, Inc.'s FORTITUDE trial of AOC 1020 in treating FSHD showed promising reductions in DUX4 gene expression and improvements in muscle function. The trial reported favorable safety and tolerability, with no serious adverse events or ...
A look at the top 10 most actives in the United States SRIVARU Holding Limited (SVMH) rose 94.8% to $0.2971 on volume of 77,516,058 shares NVIDIA Corporation (NVDA) fell 0.3% to $129.16 on volume of 39,120,242 shares Longeveron Inc. (LGVN) rose 27.0% to $3.415 on volume of 36,214,736 shar...
2024-06-14 03:54:03 ET More on Avidity Biosciences Avidity Biosciences: Strong Buy With Promising RNA Therapeutics Pipeline Avidity Biosciences announces proposed offering of common stock Avidity gains on early Phase 1/2 data for muscle disorder therapy Seeki...
2024-06-13 10:45:04 ET Micron Technology Inc. (MU) MU is trading UP for the last 5 days, and it at trading at $142.42 with volume of 5,483,382 and a one day change of $1.67 (1.19%). Micron Technology Inc. has a 52-week low of 60.50 and a 52-week high of $141.71. The business's 50-da...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) rose 3.5% to $125.2 on volume of 291,129,456 shares Apple Inc. (AAPL) rose 2.9% to $213.07 on volume of 194,159,376 shares PROSHARES TRUST (SQQQ) fell 3.9% to $8.68 on volume of 178,616,604 shares Golden He...
2024-06-12 16:08:29 ET More on Avidity Biosciences Avidity Biosciences: Strong Buy With Promising RNA Therapeutics Pipeline Avidity gains on early Phase 1/2 data for muscle disorder therapy BofA starts Avidity at buy, cites upcoming clinical data Seeking Alph...
2024-06-12 15:15:03 ET Evercore ISI analyst issues OUTPERFORM recommendation for RNA on June 12, 2024 01:25PM ET. The previous analyst recommendation was Outperform. RNA was trading at $37.348 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
Avidity Biosciences, Inc. (NASDAQ: RNA) is one of today's top gainers. The company's shares have moved 31.54% on the day to $38.04. Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjug...
A look at the top 10 most actives in the United States Cyngn Inc. (CYN) rose 20.1% to $0.1141 on volume of 103,566,471 shares Golden Heaven Group Holdings Ltd. (GDHG) rose 63.0% to $0.2917 on volume of 70,008,787 shares NVIDIA Corporation (NVDA) rose 2.9% to $124.4109 on volume of 43,082,...
2024-06-12 08:29:14 ET More on Avidity Biosciences Avidity Biosciences: Strong Buy With Promising RNA Therapeutics Pipeline BofA starts Avidity at buy, cites upcoming clinical data Seeking Alpha’s Quant Rating on Avidity Biosciences Historical earnings...
News, Short Squeeze, Breakout and More Instantly...
Avidity Biosciences Inc. Company Name:
RNA Stock Symbol:
NASDAQ Market:
Avidity Biosciences Inc. Website:
Avidity Biosciences, Inc. (NASDAQ: RNA) is the focus of IBN's latest stock spotlight. The company's shares have moved 1.85% on the day to $45.95. Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonuc...
Avidity Biosciences, Inc. (NASDAQ: RNA) is the focus of IBN's latest stock spotlight. The company's shares have moved 1.65% on the day to $45.54. Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonuc...
2024-07-14 04:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...